Literature DB >> 1540097

Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis?

A Ayala1, J M Kisala, J A Felt, M M Perrin, I H Chaudry.   

Abstract

Mice were subjected to sepsis by cecal ligation and puncture to determine whether macrophages from endotoxin-tolerant C3H/HeJ mice are also activated systemically to release inflammatory monokines associated with septic mortality. Blood levels of both tumor necrosis factor and interleukin 6 were significantly elevated during the first 1 to 4 hours of sepsis as compared with sham controls. Peritoneal macrophages from septic mice exhibited a marked spontaneous release of interleukin 1, interleukin 6, and tumor necrosis factor at 1 hour. However, the addition of endotoxin to macrophage cultures taken from septic mice had no further stimulatory effect. Sham controls alternatively showed no significant innate monokine release, but their macrophages did release increased monokine numbers in response to endotoxin. These results indicate that the spontaneous macrophage release of these monokines is comparable with that previously observed in endotoxin-sensitive mice, suggesting a common mechanism by which macrophages are primed by traumatic injury by an agent other than endotoxin to release monokines during sepsis. Thus, the administration of agents that decrease or prevent the deleterious effects of systemic inflammatory mediators during sepsis could be useful adjuvants in those clinical situations where the bacterial origin is unknown.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540097     DOI: 10.1001/archsurg.1992.01420020077011

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  11 in total

Review 1.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice.

Authors:  Yanli Ding; Chun-Shiang Chung; Sarah Newton; Yaping Chen; Stacey Carlton; Jorge E Albina; Alfred Ayala
Journal:  Shock       Date:  2004-08       Impact factor: 3.454

3.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

4.  Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury : possible connection to an interleukin-6-dependent pathway.

Authors:  U Heemann; A Szabo; P Hamar; V Müller; O Witzke; J Lutz; T Philipp
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Predictive value of interleukin 6 (IL-6), interleukin 8 (IL-8) and gastric intramucosal pH (pH-i) in major abdominal surgery.

Authors:  A Donati; D Battisti; A Recchioni; P Paoletti; G Conti; S Caporelli; E Adrario; P Pelaia; P Pietropaoli
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 6.  Adaptive and maladaptive mechanisms of cellular priming.

Authors:  D R Meldrum; J C Cleveland; E E Moore; D A Partrick; A Banerjee; A H Harken
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

7.  Independent down-regulation of central and peripheral tumor necrosis factor production as a result of lipopolysaccharide tolerance in mice.

Authors:  R Faggioni; G Fantuzzi; P Villa; W Buurman; L J van Tits; P Ghezzi
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock.

Authors:  Caroline K Hu; Fabienne Venet; David S Heffernan; Yvonne L Wang; Brian Horner; Xin Huang; Chun-Shiang Chung; Stephen H Gregory; Alfred Ayala
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Detection of neopterin, interleukin-6 and acute-phase proteins as parameters of potential monocyte activation in preoperative patients.

Authors:  W Haupt; W Hohenberger; P Klein; N V Christou
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

10.  SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome.

Authors:  Vidula T Vachharajani; Tiefu Liu; Candice M Brown; Xianfeng Wang; Nancy L Buechler; Jonathan David Wells; Barbara K Yoza; Charles E McCall
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.